Prenatal stress and maternal immune dysregulation in autism spectrum disorders: Potential points for intervention

David Q. Beversdorf, Hanna E. Stevens, Kara Gross Margolis, Judy Van de Water

Research output: Contribution to journalReview article

Abstract

Background: Genetics is a major etiological contributor to autism spectrum disorder (ASD). Environmental factors, however, also appear to contribute. ASD pathophysiology due to gene x environment is also beginning to be explored. One reason to focus on environmental factors is that they may allow opportunities for intervention or prevention.Methods and Results: Herein, we review two such factors that have been associated with a significant proportion of ASD risk, prenatal stress exposure and maternal immune dysregulation. Maternal stress susceptibility appears to interact with prenatal stress exposure to affect offspring neurodevelopment. We also explore how maternal stress may interact with the microbiome in the neurodevelopmental setting. Additionally, understanding of the impact of maternal immune dysfunction on ASD has recently been advanced by recognition of specific fetal brain proteins targeted by maternal autoantibodies, and identification of unique mid-gestational maternal immune profiles. This might also be interrelated with maternal stress exposure. Animal models have been developed to explore pathophysiology targeting each of these factors.Conclusion: We are beginning to understand the behavioral, pharmacopathological, and epigenetic effects related to these interactions, and we are beginning to explore potential mitigating factors. Continued growth in understanding of these mechanisms may ultimately allow for the identification of multiple potential targets for prevention or intervention for this subset of environmental-associated ASD cases.

Original languageEnglish (US)
Pages (from-to)4331-4343
Number of pages13
JournalCurrent Pharmaceutical Design
Volume25
Issue number41
DOIs
StatePublished - Jan 1 2019

Fingerprint

Mothers
Maternal Exposure
Surrogate Mothers
Fetal Proteins
Microbiota
Epigenomics
Autoantibodies
Animal Models
Autism Spectrum Disorder
Brain
Growth
Genes

Keywords

  • Autism spectrum disorder
  • Immune dysregulation
  • Maternal antibodies
  • Microbiome
  • Pathophysiology
  • Prenatal stress

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Prenatal stress and maternal immune dysregulation in autism spectrum disorders : Potential points for intervention. / Beversdorf, David Q.; Stevens, Hanna E.; Margolis, Kara Gross; Van de Water, Judy.

In: Current Pharmaceutical Design, Vol. 25, No. 41, 01.01.2019, p. 4331-4343.

Research output: Contribution to journalReview article

Beversdorf, David Q. ; Stevens, Hanna E. ; Margolis, Kara Gross ; Van de Water, Judy. / Prenatal stress and maternal immune dysregulation in autism spectrum disorders : Potential points for intervention. In: Current Pharmaceutical Design. 2019 ; Vol. 25, No. 41. pp. 4331-4343.
@article{757fa46a037a46dabc9eebf6a8673459,
title = "Prenatal stress and maternal immune dysregulation in autism spectrum disorders: Potential points for intervention",
abstract = "Background: Genetics is a major etiological contributor to autism spectrum disorder (ASD). Environmental factors, however, also appear to contribute. ASD pathophysiology due to gene x environment is also beginning to be explored. One reason to focus on environmental factors is that they may allow opportunities for intervention or prevention.Methods and Results: Herein, we review two such factors that have been associated with a significant proportion of ASD risk, prenatal stress exposure and maternal immune dysregulation. Maternal stress susceptibility appears to interact with prenatal stress exposure to affect offspring neurodevelopment. We also explore how maternal stress may interact with the microbiome in the neurodevelopmental setting. Additionally, understanding of the impact of maternal immune dysfunction on ASD has recently been advanced by recognition of specific fetal brain proteins targeted by maternal autoantibodies, and identification of unique mid-gestational maternal immune profiles. This might also be interrelated with maternal stress exposure. Animal models have been developed to explore pathophysiology targeting each of these factors.Conclusion: We are beginning to understand the behavioral, pharmacopathological, and epigenetic effects related to these interactions, and we are beginning to explore potential mitigating factors. Continued growth in understanding of these mechanisms may ultimately allow for the identification of multiple potential targets for prevention or intervention for this subset of environmental-associated ASD cases.",
keywords = "Autism spectrum disorder, Immune dysregulation, Maternal antibodies, Microbiome, Pathophysiology, Prenatal stress",
author = "Beversdorf, {David Q.} and Stevens, {Hanna E.} and Margolis, {Kara Gross} and {Van de Water}, Judy",
year = "2019",
month = "1",
day = "1",
doi = "10.2174/1381612825666191119093335",
language = "English (US)",
volume = "25",
pages = "4331--4343",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "41",

}

TY - JOUR

T1 - Prenatal stress and maternal immune dysregulation in autism spectrum disorders

T2 - Potential points for intervention

AU - Beversdorf, David Q.

AU - Stevens, Hanna E.

AU - Margolis, Kara Gross

AU - Van de Water, Judy

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Genetics is a major etiological contributor to autism spectrum disorder (ASD). Environmental factors, however, also appear to contribute. ASD pathophysiology due to gene x environment is also beginning to be explored. One reason to focus on environmental factors is that they may allow opportunities for intervention or prevention.Methods and Results: Herein, we review two such factors that have been associated with a significant proportion of ASD risk, prenatal stress exposure and maternal immune dysregulation. Maternal stress susceptibility appears to interact with prenatal stress exposure to affect offspring neurodevelopment. We also explore how maternal stress may interact with the microbiome in the neurodevelopmental setting. Additionally, understanding of the impact of maternal immune dysfunction on ASD has recently been advanced by recognition of specific fetal brain proteins targeted by maternal autoantibodies, and identification of unique mid-gestational maternal immune profiles. This might also be interrelated with maternal stress exposure. Animal models have been developed to explore pathophysiology targeting each of these factors.Conclusion: We are beginning to understand the behavioral, pharmacopathological, and epigenetic effects related to these interactions, and we are beginning to explore potential mitigating factors. Continued growth in understanding of these mechanisms may ultimately allow for the identification of multiple potential targets for prevention or intervention for this subset of environmental-associated ASD cases.

AB - Background: Genetics is a major etiological contributor to autism spectrum disorder (ASD). Environmental factors, however, also appear to contribute. ASD pathophysiology due to gene x environment is also beginning to be explored. One reason to focus on environmental factors is that they may allow opportunities for intervention or prevention.Methods and Results: Herein, we review two such factors that have been associated with a significant proportion of ASD risk, prenatal stress exposure and maternal immune dysregulation. Maternal stress susceptibility appears to interact with prenatal stress exposure to affect offspring neurodevelopment. We also explore how maternal stress may interact with the microbiome in the neurodevelopmental setting. Additionally, understanding of the impact of maternal immune dysfunction on ASD has recently been advanced by recognition of specific fetal brain proteins targeted by maternal autoantibodies, and identification of unique mid-gestational maternal immune profiles. This might also be interrelated with maternal stress exposure. Animal models have been developed to explore pathophysiology targeting each of these factors.Conclusion: We are beginning to understand the behavioral, pharmacopathological, and epigenetic effects related to these interactions, and we are beginning to explore potential mitigating factors. Continued growth in understanding of these mechanisms may ultimately allow for the identification of multiple potential targets for prevention or intervention for this subset of environmental-associated ASD cases.

KW - Autism spectrum disorder

KW - Immune dysregulation

KW - Maternal antibodies

KW - Microbiome

KW - Pathophysiology

KW - Prenatal stress

UR - http://www.scopus.com/inward/record.url?scp=85077945825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077945825&partnerID=8YFLogxK

U2 - 10.2174/1381612825666191119093335

DO - 10.2174/1381612825666191119093335

M3 - Review article

C2 - 31742491

AN - SCOPUS:85077945825

VL - 25

SP - 4331

EP - 4343

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 41

ER -